2025 Annual Meeting | C90 - Non-motor Parkinson’s Disease Symptoms

Date Monday 04/07/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Matthew Swan, MD

Topic(s) Movement Disorders

Learning Objectives Participants should identify the emerging role of nonmotor symptoms in Parkinson disease (PD) diagnosis,classification and subtyping. They should identify common and uncommon autonomic symptoms inPD and describe their management. They should recognize the neuropsychiatric manifestations of PD. They should identify sleep disorders such as circadian rhythm disturbances and REM behavior disorder, and describe both pharmacological and nonpharmacological management strategies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider

Teaching Styles Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Nonmotor Symptoms as a Core Feature of Parkinson Disease Matthew Swan, MD
07:05 AM - 07:40 AM PDT	Speaker	Practical Management of Autonomic Symptoms in Parkinson Disease Matthew Swan, MD
07:40 AM - 08:15 AM PDT	Speaker	Neuropsychiatric symptoms of Parkinson Disease
08:15 AM - 08:50 AM PDT	Speaker	REM behavior disorder and circadian rhythm disturbances in Parkinson Disease Aleksandar Videnovic, MD, MSc, FAAN
08:50 AM - 09:00 AM PDT	Q&A	Q&A session Matthew Swan, MD, Aleksandar Videnovic, MD, MSc, FAAN,

Faculty Disclosures
Matthew Swan, MD	The institution of Dr. Swan has received research support from Sanofi Genzyme. The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics. The institution of Dr. Swan has received research support from Parkinson's Foundation.
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion pharmaceuticals .
	No disclosure on file